Characterisation of erusiolin - a new peptide hormone

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/2001271

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Obesity and type II diabetes are epidemic diseases in Australia. Gut-derived hormones are key mediators in these diseases, due to their role in regulating appetite and blood glucose levels. Therapeutic modulation of these hormones also provides significant benefits for patients. In this proposal, we will determine the metabolic functions, such as appetite control, for a previously uncharacterised hormone, which is an unexplored therapeutic target for obesity and diabetes.

Funded Activity Details

Start Date: 01-01-2020

End Date: 01-01-2023

Funding Scheme: Ideas Grants

Funding Amount: $547,202.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

appetite regulation | gut hormones | hormone receptors | knockout mouse

Related Links